2013
DOI: 10.1007/s12281-012-0128-4
|View full text |Cite
|
Sign up to set email alerts
|

Advancing the Field: Evidence for New Management Strategies in Invasive Fungal Infections

Abstract: Invasive fungal infections (IFI) are a significant cause of morbidity and mortality in the immunocompromised. The traditional diagnostic methods of culture and histological examination lack sensitivity and often only make a diagnosis late when the fungal burden is high, reducing the chances of cure even with the availability of new more potent and less toxic antifungal agents. New non-culture-based serological and PCR assays have been developed. These appear more sensitive and are able to make an earlier diagn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 67 publications
0
8
0
Order By: Relevance
“…The high mortality rates associated with invasive infections occur despite the availability of antifungals with less toxicity and improved potency [9] . Early treatment has been related to better outcomes, but this is dependent on diagnostic tests that are both rapid and highly sensitive [12] . As traditional histology- and culture-based methods have poor sensitivity and often only make a diagnosis late when the fungal burden is high, research has turned its focus to developing improved molecular and serological assays [12] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The high mortality rates associated with invasive infections occur despite the availability of antifungals with less toxicity and improved potency [9] . Early treatment has been related to better outcomes, but this is dependent on diagnostic tests that are both rapid and highly sensitive [12] . As traditional histology- and culture-based methods have poor sensitivity and often only make a diagnosis late when the fungal burden is high, research has turned its focus to developing improved molecular and serological assays [12] .…”
Section: Discussionmentioning
confidence: 99%
“…Early treatment has been related to better outcomes, but this is dependent on diagnostic tests that are both rapid and highly sensitive [12] . As traditional histology- and culture-based methods have poor sensitivity and often only make a diagnosis late when the fungal burden is high, research has turned its focus to developing improved molecular and serological assays [12] . Several Trichosporon -specific tests have been developed in the last two decades, including PCR-based methods, flow cytometry, and proteomics [3] .…”
Section: Discussionmentioning
confidence: 99%
“…Many of the fungi in these groups are ubiquitous in nature and are not necessarily pathogenic. However, within the past few years a number of clinical cases involving infections by these fungi have been detected (mainly respiratory, skin and nail infections) (Nucci and Anaissie, 2007;Cortez et al, 2008;Knutsen and Slavin, 2011;Morrissey, 2013). Most of these cases have involved patients who are immunocompromised, and thus, relatively more vulnerable to infection by opportunistic pathogens.…”
Section: Fungimentioning
confidence: 99%
“…Invasive candidiasis (IC) continues to be a life-threatening infectious disease affecting an ever-increasing number of hospitalized patients and, of particular concern, causing considerably high morbidity and mortality. In the USA, Candida species is among the five major pathogens leading to nosocomial blood stream infections (BSIs) and causing 8–10% of nosocomial BSIs (Pappas, 2006 ; Pfaller and Diekema, 2007 ; Morrissey, 2013 ; Sievert et al, 2013 ). Though a variety of Candida species can produce invasive infection, Candida albicans ( C. albicans ) continues to be identified as a leading pathogen.…”
Section: Introductionmentioning
confidence: 99%